• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Newsletter Sign Up
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • Medical device registrations China 2022 annual report issued

Medical device registrations China 2022 annual report issued

Medical device registrations China 2022
Monday, 27 February 2023 / Published in Medical Device, News, NMPA Registration in China

Medical device registrations China 2022 annual report issued

Medical device registrations China 2022 Annual Report was issued by the NMPA (National Medical Products Administration) on February 8, 2023.

In 2022, the NMPA received a total of 10,571 applications for the initial registration, registration renewals and changes in licensing items of Class III (Domestic and Overseas) and Class II (Overseas) medical devices, decreased by 13.7% as compared to 2021. The NMPA approved a total of 11,942 applications with an increase of 5.5% as compared to 2021. The NMPA handled a total of 2,023 filing applications of imported Class I medical devices, an increase of 9.1% as compared to 2021.

Table 1. NMPA – No. of Applications and Approvals for Medical Devices and IVDs

Chart 2. Percentage Distribution of Three Types of NMPA Approvals

Chart 3. Percentage Distribution of Approvals for Medical Devices and IVDs

Chart 4. NMPA – No. of Registrations and Applications Approved from January 2016 to December 2022

Chart 5. NMPA – No. of New Registrations Approved from January 2022 to December 2022



In 2022, the NMPA approved 2,500 new registrations in total.

The provincial medical product administration (MPAs) authorities approved a total of 32,889 applications of China domestic Class II medical devices, an increase of 4.4% as compared to 2021.

The municipal medical product administration (MPAs) authorities handled a total of 28,508 filing applications of China domestic Class I medical devices, an increase of 6.5% as compared to 2021.

The top five class II and III product groups of foreign origin to be registered in 2022 were:

1. Medical imaging devices
2. Passive implant devices
3. Infusion, nursing and protective equipment
4. Dental devices
5. Neurological and cardiovascular surgical devices

The United States of America, Germany, Japan, and Korea continue to have the highest number of initial registrations for overseas medical devices as last year, taking up to 72% of the total number of initial registrations for overseas medical devices.

List of Top 10 Countries – Exporting Medical Devices to China

  1. USA
  2. Germany
  3. Japan
  4. South Korea
  5. France
  6. Switzerland
  7. United Kingdom
  8. Italy
  9. Sweden
  10. Israel

Fast-track Approval for Medical Devices

NMPA received 343 applications for special review and approval of innovative medical devices. A total of 55 medical devices have obtained the special approval to market as innovative medical devices in 2021.

From 2014 to 2022, the NMPA approved a total of 189 innovative medical devices manufactured by 134 domestic and 8 overseas enterprises.

Further information

Refer to NMPA’s original medical device registrations China 2022 annual report.

Further information concerning this topic can be obtained from contacting us:
Cisema (Hong Kong) Limited
Tel.: +852 3462 2483
officehk@cisema.com
www.cisema.com/en

GET IN TOUCH

🌐 Send us your enquiry
📚 Request our whitepapers
📣 Sign up for our newsletter

What you can read next

supervision of medical device business
Supervision of Medical Device Business Operation in China – 2022 Regulatory Updates
China Compulsory Certification List Update October 2022
China Compulsory Certification List Update – October 2022
China Still Finalizing the Details for Self-Testing on Medical Devices

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • GB9706 standards for medical electrical equipment

    GB9706 standards for medical electrical equipment – implementation details clarified

    GB9706 standards are important reference guidel...
  • Microbial limits for non-sterile chemical drugs

    Microbial limits for non-sterile chemical drugs, API and excipients – new guidelines issued

    Microbial limits for non-sterile chemical drugs...
  • Medical Device Supplementary Notice Period

    China’s Medical Device Supplementary Notice Period reverts to a one-year period

    China’s Medical Device Supplementary Notice Per...
  • Dental adhesive products registration review guidelines

    Dental adhesive products registration review guidelines issued by the CMDE

    Dental adhesive products registration review gu...
  • China’s Toothpaste Supervision & Administration Regulation

    China’s New Toothpaste Supervision & Administration Regulation: A brief guide

    China’s Toothpaste Supervision & Administra...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP